Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death (SMART-ICD)
Selective Strategy to Manage Arrhythmia Risk and Therapy With ICD
Sponsor: Institute for Clinical Evaluative Sciences
Terminated
Poor recruitment
Other Congestive Heart Failure trials with similar outcome
This NA trial investigates Congestive Heart Failure and Coronary Heart Disease and is currently terminated or withdrawn. Institute for Clinical Evaluative Sciences leads this study, which shows 7 recorded versions since 2007 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Oct 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Oct 2021 [monthly]
Terminated NA
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Jan 2017 — Jun 2018 [monthly]
Terminated NA
First recorded
Oct 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institute for Clinical Evaluative Sciences
- Ontario Ministry of Health and Long Term Care
- Unity Health Toronto
For direct contact, visit the study record on ClinicalTrials.gov .